Pregnancy-related insulin resistance becomes pathological (as in GDM) when maternal insulin production is unable to increase sufficiently to meet the pregnancy-induced changes in insulin sensitivity, resulting in maternal hyperglycaemia, and consequently increased fetal glucose levels. The gene discussed is INS; the disease is gestational diabetes.